Jessica Skarzynski | Authors


Apatinib/Chemotherapy Demonstrates Encouraging Efficacy, Tolerability in Advanced SCLC

January 28, 2021

In pretreated patients with advanced small cell lung cancer, treatment with the combination of apatinib and single-agent chemotherapy showed promising efficacy and was well-tolerated, data from a prospective phase 2 study.

Lenvatinib/Pembrolizumab Deemed Safe and Effective in Select GI Cancers

January 15, 2021

In multiple gastrointestinal tumor types, the combination of the anti-angiogenic multikinase inhibitor lenvatinib plus the anti-PD-1 antibody pembrolizumab demonstrated promising antitumor activity and a manageable safety profile, according to data presented at the 2021 ASCO Gastrointestinal Cancers Symposium.

Overall Survival in High-Risk Myelofibrosis Improved With High-Dose Imetelstat

December 05, 2020

Higher doses of telomerase inhibitor imetelstat demonstrated better overall survival, spleen response, and symptom response in patients with myelofibrosis who are relapsed after or refractory to therapy with Janus kinase inhibitors in the phase 2 IMbark study.